NCT07202039View on ClinicalTrials.gov

Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine

NANot yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 5, 2026

Primary Completion Date

October 27, 2029

Study Completion Date

February 4, 2030

Conditions
Tobacco-flavored ECSweet-Cooling ECSweet Non-cooling EC
Interventions
BEHAVIORAL

Brief individual counseling sessions

Five brief, individual counseling sessions will provide education, behavioral support, and motivational strategies to facilitate switching from combustible cigarette use to EC

Trial Locations (1)

29605

Addiction Medicine Center, Greenville

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Prisma Health-Upstate

OTHER

NCT07202039 - Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine | Biotech Hunter | Biotech Hunter